NEFL mRNA Expression Level Is a Prognostic Factor for Early-Stage Breast Cancer Patients

Xiao-Qing Li; Lin Li; Chun-Hua Xiao; Yu-Mei Feng

doi:10.1371/journal.pone.0031146

Loading metrics

Open Access

Peer-reviewed

Research Article

NEFL mRNA Expression Level Is a Prognostic Factor for Early-Stage Breast Cancer Patients

Xiao-Qing Li,

Affiliations Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⨯
Lin Li,

Affiliation Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⨯
Chun-Hua Xiao,

Affiliations Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⨯
Yu-Mei Feng

* E-mail: ymfeng@tijmu.edu.cn

Affiliations Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⨯

NEFL mRNA Expression Level Is a Prognostic Factor for Early-Stage Breast Cancer Patients

Xiao-Qing Li,
Lin Li,
Chun-Hua Xiao,
Yu-Mei Feng

Published: February 2, 2012
https://doi.org/10.1371/journal.pone.0031146

About the Authors

Xiao-Qing Li

Affiliations Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Lin Li

Affiliation Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Chun-Hua Xiao

Affiliations Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Yu-Mei Feng

* E-mail: ymfeng@tijmu.edu.cn

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: YMF. Performed the experiments: XQL LL. Analyzed the data: XQL. Contributed reagents/materials/analysis tools: XQL LL CHX YMF. Wrote the paper: XQL YMF.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Lymph nodes
Is the Subject Area "Lymph nodes" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.